Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT1 | P31749 | 10/20 | 0.41 |
| ▸ | F10 | P00742 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 3/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4807225 | 0.91 | AKT1 (0.47) | AKT1F10POLBPKMLMNA | |
| SCHEMBL4807081 | 0.89 | AKT1 (0.51) | AKT1F10 | |
| SCHEMBL4812035 | 0.88 | AKT1 (0.53) | AKT1 | |
| SCHEMBL4805601 | 0.87 | F10 (0.38) | AKT1F10SMN1; SMN2POLBMEN1 | |
| SCHEMBL4809127 | 0.85 | AKT1 (0.36) | AKT1F10SMN1; SMN2POLBPKM | |
| SCHEMBL4808662 | 0.81 | F10 (0.35) | AKT1F10SMN1; SMN2POLBMEN1 | |
| SCHEMBL19004893 | 0.81 | AKT1 (0.38) | AKT1F10POLBPKMLMNA | |
| SCHEMBL27567104 | 0.80 | LMNA (0.51) | POLBPKMLMNAMAPTMEN1 | |
| SCHEMBL6060418 | 0.80 | CYP1A2 (0.33) | — | |
| SCHEMBL4810499 | 0.79 | AKT1 (0.45) | AKT1SMN1; SMN2POLBPKMLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7388103-B2 | Cyclopentane carboxylate compounds, process and intermediates for preparing the same and use thereof | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2008-06-17 | — | — | US | disclosed |
| CN-100348571-C | 2-alkoxyl cyclopentyl ester compound, its synthesis method and application | CHINA PETROLEUM & CHEMICAL (CN) | 2007-11-14 | — | — | CN | disclosed |
| CN-1789234-A | 2-alkoxyl cyclopentyl ester compound, its synthesis method and application | CHINA PETROLEUM & CHEMICAL (CN) | 2006-06-21 | — | — | CN | disclosed |
| US-20060094843-A1 | Cyclopentane carboxylate compounds, process and intermediates for preparing the same and use thereof | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2006-05-04 | — | — | US | disclosed |
| WO-2006045246-A1 | CYCLOPENTANE CARBOXYLATE COMPOUNDS, PROCESS AND INTERMEDIATES FOR PREPARING THE SAME AND USE THEREOF | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2006-05-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060094843-A1 | Cyclopentane carboxylate compounds, process and intermediates for preparing the same and use thereof | C5, C1S, AKR1C3 | AKT1 1995/4885F10 1063/4885SMN1; SMN2 4671/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.